Holen Sie sich die Stockscreener-App
2.83
3.28%
0.09
Handel nachbörslich:
3.01
0.18
+6.36%
Schlusskurs vom Vortag:
$2.74
Offen:
$2.79
24-Stunden-Volumen:
598.86K
Relative Volume:
0.82
Marktkapitalisierung:
$6.43M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-22.71M
KGV:
-0.2417
EPS:
-11.71
Netto-Cashflow:
$-18.24M
1W Leistung:
-2.41%
1M Leistung:
-46.60%
6M Leistung:
-80.25%
1J Leistung:
-94.81%
1-Tages-Spanne:
$2.61
$2.99
1-Wochen-Bereich:
$2.61
$3.01
52-Wochen-Spanne:
$2.61
$63.00
Genprex Inc Stock (GNPX) Company Profile
Firmenname
Genprex Inc
Sektor
Branche
Telefon
512-537-7997
Adresse
1601 TRINITY STREET, BLDG. B, AUSTIN, TX
Vergleichen Sie GNPX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GNPX
Genprex Inc
|
2.83 | 6.22M | 0 | -22.71M | -18.24M | -11.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.13 | 109.90B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
723.67 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
473.29 | 61.42B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
921.80 | 56.36B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
206.78 | 44.06B | 447.02M | -1.18B | -906.14M | -6.1812 |
Genprex Inc Stock (GNPX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-01-26 | Eingeleitet | National Securities | Buy |
| 2019-04-29 | Eingeleitet | Noble Capital Markets | Outperform |
Genprex Inc Aktie (GNPX) Neueste Nachrichten
Genprex, Inc. Stock (GNPX) Opinions on Recent Preclinical Data Release - Quiver Quantitative
Is Genprex Inc. stock cheap at current valuationDollar Strength & Reliable Breakout Forecasts - Newser
Will Genprex Inc. (2DE0) stock recover faster than industryJuly 2025 Macro Moves & Reliable Volume Spike Trade Alerts - Newser
Why Genprex Inc. stock remains on buy listsWeekly Profit Summary & Safe Capital Investment Plans - Newser
Can Genprex Inc. stock beat market expectations this quarterMarket Activity Recap & Stepwise Entry/Exit Trade Alerts - BỘ NỘI VỤ
How Genprex Inc. (2DE0) stock reacts to new regulations2025 Market Trends & Daily Volume Surge Signals - BỘ NỘI VỤ
Genprex regains Nasdaq bid price compliance, receives equity extension By Investing.com - Investing.com Canada
Genprex regains Nasdaq bid price compliance, receives equity extension - Investing.com
Genprex reports phase 1 data for lung cancer gene therapy By Investing.com - Investing.com Nigeria
Data from Genprex's Acclaim-1 Phase 1 Gene Therapy Clinical Tria - GuruFocus
Genprex (GNPX) Shares Positive Acclaim-1 Trial Data for Lung Can - GuruFocus
Genprex reports phase 1 data for lung cancer gene therapy - Investing.com
Data from Genprex's Acclaim-1 Phase 1 Gene Therapy Clinical Trial Published in Clinical Lung Cancer - cnhinews.com
Genprex files prospectus supplement for up to $75 million at-the-market offering By Investing.com - Investing.com Australia
Genprex files prospectus supplement for up to $75 million at-the-market offering - Investing.com Australia
Genprex Inc. (GNPX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Genprex Announces $75 Million Stock Offering - MSN
[S-1] Genprex, Inc. Files IPO Registration Statement | GNPX SEC FilingForm S-1 - Stock Titan
Genprex, Inc. Announces $75 Million Stock Offering - TradingView
[8-K] Genprex, Inc. Reports Material Event | GNPX SEC FilingForm 8-K - Stock Titan
Can Genprex Inc. (2DE0) stock sustain revenue momentumWeekly Stock Summary & Safe Swing Trade Setup Alerts - newser.com
How Genprex Inc. stock benefits from tech adoption2025 Valuation Update & Reliable Volume Spike Trade Alerts - newser.com
Is Genprex Inc. stock attractive for retirement portfoliosJuly 2025 Breakouts & High Conviction Trade Alerts - newser.com
Why Genprex Inc. (2DE0) stock attracts wealthy investorsPortfolio Gains Summary & Fast Gain Swing Trade Alerts - newser.com
Is Genprex Inc. (2DE0) stock at risk of policy regulationWeekly Profit Report & Expert Approved Momentum Trade Ideas - newser.com
Will Genprex Inc. (2DE0) stock outperform global peersJuly 2025 Gainers & Consistent Growth Equity Picks - newser.com
Published on: 2025-11-19 22:26:30 - newser.com
Is Genprex Inc. (2DE0) stock undervalued at current priceWeekly Profit Analysis & Growth Focused Investment Plans - newser.com
Can Genprex Inc. (2DE0) stock reach $200 price targetJuly 2025 Retail & Short-Term Trading Alerts - newser.com
Will Genprex Inc. stock reach Wall Street targets2025 Technical Patterns & Long-Term Growth Portfolio Plans - newser.com
Will Genprex Inc. (2DE0) stock remain on Wall Street radarBull Run & Real-Time Chart Breakout Alerts - newser.com
Published on: 2025-11-19 13:34:52 - newser.com
Can Genprex Inc. (2DE0) stock beat analyst consensusEntry Point & Free Verified High Yield Trade Plans - newser.com
MSN Money - MSN
Genprex Adds Clinical Trial Site for Acclaim-1 and Acclaim-3 Lun - GuruFocus
Genprex Expands Clinical Trials with New Site Addition - TipRanks
Genprex Expands Clinical Trials for Lung Cancer Therapy - TradingView
Genprex Adds Clinical Trial Site for Acclaim-1 and Acclaim-3 Lung Cancer Clinical Trials - PR Newswire
Finanzdaten der Genprex Inc-Aktie (GNPX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.18%
0.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):